A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate (PROTECt)
A Prospective, Randomized Trial Comparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Cardiac Catheterization
Sponsor: University of Nebraska
Terminated
Technical measurement problems led to unreliable or uninterpretable data.
Other terminated trials from University of Nebraska
Other Nephropathy trials with similar outcome
Listed as NCT00579995, this NA trial focuses on Nephropathy and remains terminated or withdrawn. Sponsored by University of Nebraska, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Oct 2023 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2021 — Oct 2023 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Nebraska
For direct contact, visit the study record on ClinicalTrials.gov .